Highlights New analysis of ATH434-201 double blind trial strengthens efficacy signal at high dose levelPositive data from ATH434-202 open-label trial demonstrates similar treatment effect in advanced ...
The lesson is not to fear a conspiracy, but to keep refining our definitions, sharpening our science, and remembering that ...
Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...
KB407 utilizes a replication-defective HSV-1 vector to deliver full-length CFTR to the airway epithelium. The interim readout ...
An international report highlights numerous irregularities in the mass transfers of specimens to the private facility in ...
The musical artist claimed the company turned a blind eye to fake users allegedly boosting songs by the "Hotline Bling" ...
Q3 2025 Earnings Call November 10, 2025 5:00 PM ESTCompany ParticipantsKirsten Newquist - CEO & DirectorEdward Kirnbauer - ...
Originally conceived by DJ Salisbury and Larry Moore, Moonshine & Mistletoe (An Appalachian Christmas Celebration) features a ...
Operator: Greetings, and welcome to the Paysafe Third Quarter 2025 Earnings Conference Call and Webcast. At this time, all ...
A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...
The UK beer & cider market shows opportunities in premium and zero-alcohol segments, with the latter growing by 10.6% due to health trends. Discount retailers are also rising as consumers seek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback